Highlights From The 2025 FLASCO Early Lung Cancer Summit by Estela Rodriguez
The 2025 FLASCO Early Lung Cancer Summit was held on January 24-25, bringing together experts to discuss some of the most pressing challenges in the diagnosis and treatment of lung cancer.
The theme, “Challenges in Lung Cancer and The Need for Artificial Intelligence and Blood Biomarkers,” focused on the integration of advanced technologies and biomarkers to improve patient outcomes. Over the two-day event, leading specialists shared valuable insights on how artificial intelligence is transforming clinical decision-making and how blood-based biomarkers are paving the way for earlier detection and more personalized treatment approaches. The summit fostered impactful discussions and collaborations, contributing to the ongoing advancement of lung cancer care.
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared about the conference on social media:
Emily Matthews on how to build a comprehensive lung cancer screening program
“Great presentation by Emily Matthews on how to build a comprehensive lung cancer screening program addressing education, access and logistic barriers.
How to deploy a mobile unit and challenges of making it work when you serve underserved / uninsured communities.”
Role of EBUS for biomarker testing and importance of communication
“Dr Gerard Silvestri discusses role of EBUS for biomarker testing and importance of communication and education with pulmonologist and proper tissue collection to decrease turnaround times.”
Coral Olazagasti leads multi-disciplinary discussion on NSCLC
“Coral Olazagasti leads great multi-disciplinary discussion on mgmt of early-stage NSCLC, featuring experts Jacques P. Fontaine, Brian Gotkin, and FLASCO President Maen Hussein.”
Role of AI in risk-based modeling
“Dr Alberto Chiappori highlights role of AI in risk-based modeling and prediction for early detection of lung cancer.”
AI and screening for non smokers
“Starting today with great speakers on lung cancer screening incident al noduled and AI and screening for non smokers with Drs Claudia Henschke, David Yankelevitz, Mount Sinai, Alberto Chiappori.”
AI is the worst it will ever be
“FLASCO Early Stage Lung Cancer Summit was all about AI and cancer screening.
Dr William Mayfield breaks down the promise and current challenges of using AI to optimize the LC screening process. “AI is the worst it will ever be””
Dr Gerald Silvestri addresses one of the biggest challenges
“Dr Gerald Silvestri addresses one of the biggest challenges in increasing access to underserved pollutions- insurance coverage and access to basic needs in general.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023